Clinical Resources

MDS Curriculum Track: Parkinson's Disease - Subtypes, Mimics, Treatment, and Supportive Care

On Demand

10.25 Hours

Experienced / Intermediate

998The MDS Curriculum Track: Parkinson&rsquo;s Disease &ndash; Subtypes, Mimics, Treatment, and Supportive Care will provide an in-depth approach to patients with Parkinson&rsquo;s disease, including management of non-motor symptoms and strategies for advanced Parkinson&rsquo;s disease. An overview of the emerging role of neuroimaging biomarkers and symptomatic and disease-modifying clinical trials will be presented.6150.00https://education.movementdisorders.org/Detail/998/MDS-Curriculum-Track:-Parkinson's-Disease---Subtypes,-Mimics,-Treatment,-and-Supportive-Carehttps://education.movementdisorders.org/Upload/ActivityImages/PD-Track_lvl2195007.jpghttps://education.movementdisorders.org/Upload/BannerImages/PD-Track_Lvl2786044.jpg2025-07-08T00:00:002028-07-08T00:00:00MDS Education<p><span style="background-color: null;"><strong>FACULTY AND RESOURCES</strong></span></p><p>For a complete list of the faculty and resources included in this curriculum track, please click <a class="fr-file" href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/MDS Curriculum Track - Parkinson’s Disease – Subtypes, Mimics, Treatment, and Supportive Care - Faculty and Resources_08072025094258.pdf" target="_blank">here.</a></p><p><strong>Content Curated By:</strong></p><p>MDS Curriculum Development Sub-Committee</p><p><br></p><p><span style="background-color: null;"><strong>MDS CURRICULUM TRACK USER GUIDE</strong></span></p><p>For step-by-step guidance on navigating and completing MDS Curriculum Tracks, you may view the user guide linked <a class="fr-file" href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/MDS Curriculum Track User Guide_07032025121057.pdf" target="_blank">here</a> or watch the tutorial video below.</p><p><br></p><p><span class="fr-video fr-dvb fr-draggable" contenteditable="false" draggable="false">&nbsp;<video class="fr-draggable fr-fvc fr-dvi" controls="" height="300" width="533"><source src="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Tutorial Video_07032025105035.mp4" type="video/mp4">&nbsp;Your browser does not support HTML5 video.</video>&nbsp;</span></p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:&nbsp;</p><p>1. Demonstrate knowledge about the clinical subtyping in Parkinson&rsquo;s disease.</p><p>2. Demonstrate knowledge of atypical parkinsonism and its management.</p><p>3. Manage motor and non-motor symptoms of Parkinson&rsquo;s disease and identify the best available treatment option for each patient.</p><p>4. Identify and manage patients with Parkinson&rsquo;s disease who could benefit from advanced therapies.</p><p>5. Implement current approaches to the end-stage Parkinson&rsquo;s disease and atypical parkinsonism.</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, students, residents, primary care providers, internists, allied health, non-neurology specialists, and industry who have some prior experience with Parkinson&#39;s disease.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/MDS-Curriculum-Track-Parkinsons-Disease---Subtypes-Mimics-Treatment-and-Supportive-Care.htmMDS Curriculum Track: Parkinson's Disease - Subtypes, Mimics, Treatment, and Supportive CareLevel: Experienced/Intermediate2025-07-08T12:00:13.08000Experienced / IntermediateOn-DemandBasic/Translational NeuroscienceEtiology &amp; PathophysiologyNon-motor Symptoms/DisordersParkinson Disease/Hypokinetic Movement DisordersTherapies-PharmacologicalTherapies-Surgical

Journal CME 40.07: Intraputaminal Delivery of Adeno-Associated Virus Serotype 2–Glial Cell Line–Derived Neurotrophic Factor in Mild or Moderate Parkinson’s Disease

On Demand

60 Minutes

Foundational / Beginner

1002<p>The Journal CME 40.07 article aims to assess safety and preliminary clinical outcomes of optimized bilateral intraputaminal infusion of<br />a single, higher dose of AAV2-GDNF (product code AB-1005) for PD after 18 months.</p>Amber D. Van Laar, MD601.00https://education.movementdisorders.org/Detail/1002/Journal-CME-40-07:-Intraputaminal-Delivery-of-Adeno-Associated-Virus-Serotype-2–Glial-Cell-Line–Derived-Neurotrophic-Factor-in-Mild-or-Moderate-Parkinson’s-Diseasehttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2025-06-25T00:00:002026-06-25T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.07%20-%20Disclosures_24062025111321.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><ol><li>Assess the safety and tolerability of AAV2-GDNF gene therapy</li><li>Understand early motor and nonmotor clinical outcomes following gene therapy</li><li>Evaluate the impact of infusion technique and putaminal coverage on therapeutic outcomes</li></ol><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Journal-CME-40.07-Intraputaminal-Delivery-of-Adeno-Associated-Virus-Serotype-2Glial-Cell-LineDerived-Neurotrophic-Factor-in-Mild-or-Moderate-Parkinsons-Disease.htmJournal CME 40.07: Intraputaminal Delivery of Adeno-Associated Virus Serotype 2–Glial Cell Line–Derived Neurotrophic Factor in Mild or Moderate Parkinson’s DiseaseJournal CME 40.072025-07-01T15:01:03.21300Foundational / BeginnerOn-DemandParkinson Disease/Hypokinetic Movement DisordersTherapies-Surgical

Journal CME 40.06: Long-Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10-Year Follow-Up

On Demand

60 Minutes

Foundational / Beginner

1001<p>The Journal CME 40.06 article aims to evaluate long-term efficacy and safety of pallidal neurostimulation in patients with isolated generalized or segmental dystonia.</p>Patricia Krause, MD601.00https://education.movementdisorders.org/Detail/1001/Journal-CME-40-06:-Long-Term-Outcomes-on-Pallidal-Neurostimulation-for-Dystonia:-A-Controlled,-Prospective-10-Year-Follow-Uphttps://education.movementdisorders.org/Upload/ActivityImages/Journal-CME562837664663.jpg2025-06-19T00:00:002026-06-19T00:00:00<p><strong>ACCREDITATION STATEMENT</strong></p><p>This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). The International Parkinson and Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.</p><p><br></p><p><strong>CREDIT DESIGNATION STATEMENT</strong></p><p>The International Parkinson and Movement Disorder Society designates this activity for a maximum of 1 <em>AMA PRA Category 1 Credits&trade;</em>. Physicians should only claim credit commensurate with the extent of their participation.</p><p><br></p><p><strong>FACULTY DISCLOSURE</strong></p><p>All individuals in control of content for this activity are required to disclose all financial relationships with ineligible companies (as defined by the ACCME) over the last 24 months. Disclosure information is available <a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Journal%20CME%2040.06%20-%20Disclosures_18062025104206.pdf" rel="noopener noreferrer" target="_blank">HERE</a>. All relevant financial relationships have been mitigated in advance of this program.</p><p><br></p><p><strong>METHOD OF PARTICIPATION</strong></p><p>Each module will take approximately one (1) hour to complete. Upon reading the article, participants will take a post-test and must receive a grade of 75% or higher to pass. Participants are allowed multiple attempts to complete the post-test. Once the post-test is passed, participants are required to complete the module evaluation.</p><p><br></p><p><strong>SATISFACTORY COMPLETION</strong></p><p>Participants must complete an evaluation for each session they attend to receive continuing medical education credit. Your chosen session(s) must be attended in their entirety. Partial credit for individual sessions is not available.</p><p><br></p><p><strong>CONTENT VALIDITY STATEMENT</strong></p><p>All recommendations involving clinical medicine in MDS activities are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the case of patients. All scientific research referred to, reported or used in CME in support or justification of a patient care recommendations conforms to the generally accepted standards of experimental design, data collection and analysis. Activities that promote recommendations, treatment or manners of practicing medicine not within the definition of CME or are knowing to have risks or dangers that outweigh the benefits or are knowing to be ineffective in the treatment of patients do not constitute valid CME.</p>MDS Education<p><strong>COURSE PURPOSE</strong></p><p>Journal CME highlights various articles covering relevant issues, developments and research topics in the area of movement disorders. Articles are selected from Movement Disorders, the official Journal of the International Parkinson and Movement Disorder Society.</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>Upon completion of this activity, learners will be able to:</p><p>1. Evaluate the long-term efficacy of pallidal neurostimulation</p><p>2. Analyze the safety and psychosocial outcomes of pallidal neurostimulation</p><p>3. Identify predictors and causes of DBS treatment failure</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, other health professionals, researchers, policy makers from throughout the world, both MDS members and non-members, who interact with patients living with Movement Disorders.</p><p><br></p><p><strong>HARDWARE AND SOFTWARE REQUIREMENTS</strong></p><p>1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.</p><p>2. Compatible with Windows PC and MAC (256 MB of RAM or higher).</p><p>3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher.</p><p>4. Adobe Flash Player 12.0 (or higher).</p><p>5. Adobe Reader to print certificate.</p>0/Courses/Journal-CME-40.06-Long-Term-Outcomes-on-Pallidal-Neurostimulation-for-Dystonia-A-Controlled-Prospective-10-Year-Follow-Up.htmJournal CME 40.06: Long-Term Outcomes on Pallidal Neurostimulation for Dystonia: A Controlled, Prospective 10-Year Follow-UpJournal CME 40.062025-07-01T15:01:01.59000Foundational / BeginnerOn-DemandHyperkinetic Movement DisordersTherapies-Surgical

Botulinum Toxin Convergence on Skills for Movement Disorders and Spasticity (ABCs-MDS)

In-Person

Metro Manila

Nov 25, 2025 - Nov 26, 2025

Experienced / Intermediate, Foundational / Beginner

1006<p>The <em>MDS-AOS Botulinum Toxin Convergence on Skills for Movement Disorders and Spasticity (ABCs-MDS)</em> course is designed for adult and child neurologists who diagnose, treat, or manage patients with movement disorders and spasticity using botulinum toxin. This 2-day thorough and intensive training program incorporates balanced and comprehensive didactic lectures, the opportunity to ask questions on uncertain areas, and true assessment of understanding of concepts and readiness for BoNT injections.<br /><strong><br />REGISTRATION DEADLINE</strong>: November 10, 2025<strong></strong></p>7350.00https://education.movementdisorders.org/Detail/1006/MDS-AOS-Botulinum-Toxin-Convergence-on-Skills-for-Movement-Disorders-and-Spasticity-(ABCs-MDS)https://education.movementdisorders.org/Upload/ActivityImages/25AOSSKILLS_202x108702717.jpghttps://education.movementdisorders.org/Upload/BannerImages/25AOSSKILLS-BoTox_783x404490796.jpg2025-11-25T00:00:002025-11-26T00:00:00EDSA Shangri-La Hotel, Metro Manila<p><br></p><p><br></p>MDS Education<p><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/25AOSSKILLS Course Schedule_02072025102612.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Course schedule_23012024043738.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><strong>Course Schedule&nbsp;</strong><a href="https://form.jotform.com/251695717737168" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Travel assistance_23012024043912.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><strong>Travel Bursary &nbsp; &nbsp; &nbsp; &nbsp;</strong><a href="https://d1t84l7yt030ad.cloudfront.net/FroalaFiles/Faculty Listing_LMS-faculty only_02072025103113.pdf" rel="noopener noreferrer" target="_blank"><img src="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/Faculty Details_23012024043924.png" style="width: 125px; height: 125px;" class="fr-fic fr-dib"></a><strong>Course Faculty</strong></p><p><br></p><p><em>Schedule as of July 2, 2025&nbsp;</em></p><p><strong><em><span style="color: rgb(175, 38, 38);">Travel Bursary Deadline:</span></em></strong><em>&nbsp;August 15, 2025</em></p><p><br></p><p><strong>REGISTRATION FEES</strong><br><strong>Members:</strong>&nbsp; $150 USD<br><strong>Members</strong><strong>: Junior / HP / Basic Science / No Fee:</strong>&nbsp;$100 USD<br><strong>Non-Members*:</strong>&nbsp;$200 USD</p><p>*<em>Non-members wishing to apply for MDS Membership to receive the MDS Member rate for this course will need to apply for membership no later than 2 weeks in advance of the close of registration.</em></p><p><a href="https://s3-us-east-2.amazonaws.com/mds-lms/FroalaFiles/VISA%20STATEMENT%20CANCELLATION%20LANGUAGE_24012024041714.pdf" rel="noopener noreferrer" target="_blank">Click here to view the MDS Regional Course Cancellation Policy &amp; Visa Assistance Information</a></p><p><br></p><p><span style="background-color: null;"><strong>COURSE VENUE</strong></span></p><p><a href="https://www.shangri-la.com/manila/edsashangrila/" rel="noopener noreferrer" target="_blank">EDSA Shangri-La Hotel</a></p><p>1 Garden Way, Ortigas Center, Mandaluyong City</p><p>1550 Metro Manila, Philippines</p><p><br></p><p><strong>LEARNING OBJECTIVES</strong></p><p>At the conclusion of the activity, learners will be able to:</p><p>1. Define the indications of botulinum toxin injection&nbsp;</p><p>2. Articulate the formulations, preparation, and dilution of botulinum toxin injection</p><p>3. Identify selection of muscles for botulinum toxin injection in patients with movement disorders and spasticity</p><p>4. Demonstrate injection techniques using surface anatomy, electromyography, electrical stimulation and ultrasonography</p><p><br></p><p><strong>INTENDED AUDIENCE</strong></p><p>This activity is intended for clinicians, movement disorder specialists, general neurologists, fellows, residents, and physio / physical therapists.</p>Metro Manila0/Courses/Botulinum-Toxin-Convergence-on-Skills-for-Movement-Disorders-and-Spasticity-ABCs-MDS.htmBotulinum Toxin Convergence on Skills for Movement Disorders and Spasticity (ABCs-MDS)2025-06-27T12:01:03.51000Experienced / IntermediateFoundational / BeginnerIn-PersonCare ModelsHyperkinetic Movement DisordersOther Movement DisordersTherapies-OtherTherapies-Pharmacological